10th September 2018
The 17th Migraine Trust International Symposium comes to an end
Interactive learning and knowledge sharing
The 17th Migraine Trust International Symposium (MTIS) that took place in London this week was a great success. It brought together 800 clinicians and scientists to share the latest research findings and discuss current trends in treatment and prevention.
We enjoyed four incredible days of interactive learning and knowledge sharing.
Our mission is to raise the profile of migraine and headache and make the world that little bit better for patients with migraine – and we came away from MTIS full of excitement, hope and promise.
The future is truly bright for medical research in the field of migraine.
Some of the highlights of MTIS included Dr Richard Lipton sharing his expertise on comorbidities and migraine. We learnt that migraine is comorbid with depression, anxiety, epilepsy, snoring and sleep apnea.
Dr Nunu Lund presented her paper on chronobiology and sex differences in cluster headache and received the 2018 Giuseppi Nappi Award from Professor Peter Goadsby and Professor Cristina Tassorelli.
Dr Gisela Terwindt, who gave the MacDonald Critchley Lecture, delved into the role that hormones play in her lecture about migraine and women.
We then had almost two hundred people attend the public event for people affected by migraine. Nobody is more eager to learn about the latest developments in research and treatment than those whose lives it will change.
Our next symposium will be taking place in London in two years’ time, so put the 10-13 September 2020 in your diary if you would like to attend.